The RCPCH is pleased to offer this course at a reduced rate. Please note the fees may be subject to change.
Members (Junior, Ordinary, Fellow, Affiliate, Associate):
Consultant - £150
Trainees, SAS Doctor, Nurse & AHPs - £120
Non-Members:
Trainees, SAS Doctors, Nurses & AHPs - £120
All other non-members - £215
Who is the course for?
This virtual course is principally aimed at paediatricians, dietitians, psychiatrists, gastroenterologists, allied health professionals and senior nursing staff involved in delivering care in paediatric settings to patients under 18 who present with ARFID. ARFID is increasingly encountered in day-to-day paediatric practice and can result in significant morbidity and even mortality. ARFID requires a different approach to other types of eating disorders.
Aim
- Increase knowledge, skills and confidence in assessing a child or young person with ARFID in paediatric settings
- Help delegates develop an approach to the management of children and young people with ARFID
Individual learning outcomes
By the end of this course, you will be able to:
- develop a clinical approach to the recognition and management of patients with Avoidant Restrictive Food Intake Disorder (ARFID)
- distinguish the important differences in diagnosis and management approach between ARFID and other types of eating difficulties/disorders
- understand the role of the Paediatrician in the medical care of patients with ARFID
- understand the role of the dietician and the nutritional approach in patients with ARFID
- understand the role of Allied Health Professionals
- gain a broader awareness of potential adaptations for neurodiverse patients.
Course requirements
To participate in this online course, you will need access to:
- Windows or Mac Computer (laptop/desktop or tablet)
- internet connection
- microphone and speaker - either using the built-in microphone/speaker or a headset connected to your laptop/desktop or tablet
- webcam - either using a built-in webcam or a separate webcam connected to your laptop/desktop or tablet.